Authors: LOWENTHAL RM FABERES C MARIT G BOIRON JM CONYMAKHOUL P PIGNEUX A AGAPE P VEZON G BOUZGAROU R DAZEY B FIZET D BERNARD P LACOMBE F REIFFERS J

Citation: Rm. Lowenthal et al., FACTORS INFLUENCING HEMATOPOIETIC RECOVERY FOLLOWING CHEMOTHERAPY-MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FORHEMATOLOGICAL MALIGNANCIES - A RETROSPECTIVE ANALYSIS OF A 10-YEAR SINGLE INSTITUTION EXPERIENCE, Bone marrow transplantation, 22(8), 1998, pp. 763-770

Authors: DAZEY B BOIRON JM HAMSANY M CONYMAKHOUL P AGAPE P PIGNEUX A VEZON G REIFFERS J

Citation: B. Dazey et al., CD34-BLOOD - ALLOGENEIC STEM-CELLS TRANSPLANTATION (ASCT) FOR REFRACTORY LEUKEMIA( HEMATOPOIETIC PROGENITOR CELLS SELECTION FROM PERIPHERAL), Bone marrow transplantation, 21, 1998, pp. 63-63

Authors: BOIRON JM DAZEY B CONYMAKHOUL P PIGNEUX A AGAPE P BOUZGARROU R REIFFERS J

Citation: Jm. Boiron et al., CD34-POSITIVE PERIPHERAL-BLOOD STEM-CELL (PBSC) AUTOLOGOUS TRANSPLANTATION WITH OR WITHOUT GROWTH-FACTORS POSTTRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 64-64

Authors: FABRE E BOIRON JM PIGNEUX A DAZEY B AGAPE P CONYMAKHOUL P LACOMBE F BOUZGARROU R REIFFERS J

Citation: E. Fabre et al., THIOTEPA AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR HIGH-RISK PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 340-340

Authors: FOLLEA G HERVE P ANDREU G BIDET JM BOUDARD D DAZEY B NOEL L PIQUET Y

Citation: G. Follea et al., VIRAL INACTIVATION OF LABILE BLOOD PRODUCTS, Transfusion clinique et biologique, 3(2), 1996, pp. 113-123

Authors: FOLLEA G ANDREU G BIDET JM BOUDARD D DAZEY B DELACHAUX V NOEL L PEYRE R PIQUET Y

Citation: G. Follea et al., WHICH PLACE FOR FROZEN FRESH PLASMA VIRO- INACTIVATED BY METHYLENE-BLUE AND PHOTOSENSITIZATION, Transfusion clinique et biologique, 1(1), 1994, pp. 41-43